Quantinno Capital Management LP Boosts Stake in Chemed Co. (NYSE:CHE)

Quantinno Capital Management LP increased its stake in Chemed Co. (NYSE:CHE) by 29.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,587 shares of the company’s stock after acquiring an additional 365 shares during the period. Quantinno Capital Management LP’s holdings in Chemed were worth $954,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. American National Bank & Trust purchased a new position in shares of Chemed in the 3rd quarter worth about $61,000. GAMMA Investing LLC lifted its position in Chemed by 60.5% in the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock worth $83,000 after buying an additional 52 shares during the last quarter. Quarry LP lifted its position in Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after buying an additional 166 shares during the last quarter. Sound Income Strategies LLC purchased a new stake in Chemed in the third quarter worth approximately $201,000. Finally, Farther Finance Advisors LLC raised its stake in shares of Chemed by 2,314.3% during the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after acquiring an additional 324 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

CHE has been the subject of a number of research reports. Royal Bank of Canada cut their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Chemed Price Performance

Shares of Chemed stock opened at $546.69 on Friday. The stock has a market capitalization of $8.23 billion, a P/E ratio of 27.62, a price-to-earnings-growth ratio of 2.32 and a beta of 0.46. Chemed Co. has a one year low of $523.33 and a one year high of $654.62. The business’s 50 day simple moving average is $570.70 and its two-hundred day simple moving average is $564.64.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.32 earnings per share. Sell-side analysts expect that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 annualized dividend and a dividend yield of 0.37%. Chemed’s payout ratio is presently 10.11%.

Insider Activity at Chemed

In other Chemed news, Director George J. Walsh III sold 400 shares of the company’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the transaction, the director now directly owns 3,046 shares in the company, valued at approximately $1,819,893.62. This represents a 11.61 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total transaction of $421,353.84. Following the sale, the executive vice president now directly owns 18,287 shares in the company, valued at $10,526,362.94. The trade was a 3.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,132 shares of company stock worth $3,003,502 in the last 90 days. Company insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.